These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24800907)

  • 1. Vildagliptin in renal impairment.
    Dongre N; Kothny W
    J Nephrol; 2014 Jun; 27(3):349. PubMed ID: 24800907
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral hypoglycemics and diabetic nephropathy.
    Hadler NM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):159-62. PubMed ID: 18178782
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk.
    Schernthaner G; Schernthaner GH
    J Nephrol; 2013; 26(6):975-85. PubMed ID: 23807645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Bothe D
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2390; author reply 2390-1. PubMed ID: 23132160
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes: Glycemic and blood-pressure control--lower is not better.
    Ruilope LM
    Nat Rev Nephrol; 2012 Feb; 8(4):199-200. PubMed ID: 22330972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 11. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Heerspink HJ; van Raalte DH
    Lancet Diabetes Endocrinol; 2015 May; 3(5):367-81. PubMed ID: 25943756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
    Aperis G
    J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope?
    Ingelfinger JR; Rosen CJ
    N Engl J Med; 2016 Jul; 375(4):380-2. PubMed ID: 27331286
    [No Abstract]   [Full Text] [Related]  

  • 14. [New oral hypoglycemic drugs in diabetic kidney disease].
    Dylewska M; Graczyk M
    Wiad Lek; 2017; 70(6 pt 2):1193-1196. PubMed ID: 29533912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet need in diabetic nephropathy: failed drugs or trials?
    de Zeeuw D; Heerspink HJL
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):638-640. PubMed ID: 27160545
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease.
    Wanner C
    Nat Rev Nephrol; 2018 Feb; 14(2):78-80. PubMed ID: 29307892
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
    Fang V; Wazny LD; Raymond CB
    CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.
    Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T
    Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of hyperglycemia in patients with chronic kidney disease.
    Aires Neto P; Gomes HV; Campos M
    J Nephrol; 2013; 26(4):629-35. PubMed ID: 23807643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic patient with liver or kidney disease. Which antidiabetics are allowed?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jun; 152(22):18. PubMed ID: 20590025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.